SCHEMBL10167752

SCHEMBL10167752

CC/C=C(\C#N)C(=O)OC

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C9 P11712 1/20 0.42
ADORA2A P29274 1/20 0.40
ADORA2B P29275 1/20 0.40
ADORA1 P30542 1/20 0.40
POLB P06746 1/20 0.38
APP P05067 2/20 0.37
NPSR1 Q6W5P4 2/20 0.37
NPC1 O15118 1/20 0.37
RAB9A P51151 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
KDM4E B2RXH2 5/20 0.36
ALDH1A1 P00352 9/20 0.35
MAPT P10636 4/20 0.35
KMT2A Q03164 3/20 0.35
LMNA P02545 1/20 0.35
TNNI3 P19429 1/20 0.35
CRHBP P24387 1/20 0.35
TNNT2 P45379 1/20 0.35
KLK7 P49862 1/20 0.35
TNNC1 P63316 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2671871 1.00 CYP2C9 (0.42) CYP2C9ADORA2AADORA2BADORA1POLB
SCHEMBL4135131 0.84 CYP2C9 (0.40) CYP2C9POLBNPSR1NPC1RAB9A
SCHEMBL17859724 0.84 CYP2C9 (0.40) CYP2C9ADORA2AADORA2BADORA1POLB
SCHEMBL27679283 0.84 CYP2C9 (0.40) CYP2C9ADORA2AADORA2BADORA1POLB
SCHEMBL10136090 0.83 ADORA2A (0.40) CYP2C9ADORA2AADORA2BADORA1POLB
SCHEMBL4072774 0.83 ADORA2A (0.40) CYP2C9ADORA2AADORA2BADORA1POLB
SCHEMBL1324360 0.82 CYP2C9 (0.41) CYP2C9POLBNPSR1NPC1RAB9A
SCHEMBL11269373 0.82 CYP2C9 (0.62) CYP2C9POLBNPSR1NPC1RAB9A
SCHEMBL4181528 0.82 CYP2C9 (0.41) CYP2C9POLBNPSR1NPC1RAB9A
SCHEMBL167038 0.82 CYP2C9 (0.62) CYP2C9POLBNPSR1NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170101384-A1 ANDROGEN RECEPTOR ANTAGONISTS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2017-04-13 US disclosed
US-20120165437-A1 AQUEOUS PIGMENT DISPERSION AND AQUEOUS INK FOR INKJET RECORDING FUJIFILM CORPORATION (JP) 2012-06-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170101384-A1 ANDROGEN RECEPTOR ANTAGONISTS AR, LHCGR, FSHR CYP2C9 1497/4885ADORA2A 110/4885ADORA2B 373/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.